Zobrazeno 1 - 10 of 22 pro vyhledávání: '"Budiwan, Sumarsono"'
1
Akademický článek
The prevalence and bother of lower urinary tract symptoms in men and women aged 40 years or over in Taiwan
Autor: Shih-Ping Liu, Yao-Chi Chuang, Budiwan Sumarsono, Hui-Chen Chang
Publikováno v: Journal of the Formosan Medical Association, Vol 118, Iss 1, Pp 170-178 (2019)
Background/Purpose: The prevalence of lower urinary tract symptoms (LUTS) in men and women in the general population in Taiwan is unclear. Community-based data on the epidemiology and effects of LUTS would therefore help improve understanding of the
Externí odkaz: https://doaj.org/article/e7f646826f794bdd80af70eaa9a45bb2
Zobrazit plný text záznamu
2
Akademický článek
The prevalence of lower urinary tract symptoms in population aged 40 years or over, in South Korea
Autor: Tag Keun Yoo, Kyu-Sung Lee, Budiwan Sumarsono, Sung-Tae Kim, Hyun-Jung Kim, Hyun-Cheol Lee, Sun-Hwa Kim
Publikováno v: Investigative and Clinical Urology, Vol 59, Iss 3, Pp 166-176 (2018)
Purpose: Lower urinary tract symptoms (LUTS) can be distressing and socially isolating, and the economic impact can be substantial. Further data to characterize the epidemiology and effects of LUTS in South Korea would be beneficial. Materials and Me
Externí odkaz: https://doaj.org/article/dfa7e66a76e3436aa8fab0b43a01dd39
Zobrazit plný text záznamu
3
Akademický článek
Association of lower urinary tract symptoms and OAB severity with quality of life and mental health in China, Taiwan and South Korea: results from a cross-sectional, population-based study
Autor: Kyu-Sung Lee, Tag Keun Yoo, Limin Liao, Jianye Wang, Yao-Chi Chuang, Shih-Ping Liu, Romeo Chu, Budiwan Sumarsono
Publikováno v: BMC Urology, Vol 17, Iss 1, Pp 1-10 (2017)
Abstract Background Lower urinary tract symptoms (LUTS) and overactive bladder (OAB) symptoms have a substantial effect on quality of life (QoL). We report QoL and mental health results from a LUTS prevalence study in three Asian countries. Methods A
Externí odkaz: https://doaj.org/article/cd753ede13624430b79369ad610cd5ea
Zobrazit plný text záznamu
5
Prevalence, severity, and associated factors in women in East Asia with moderate-to-severe vasomotor symptoms associated with menopause
Autor: Qi, Yu, Hee-Dong, Chae, Sheng-Mou, Hsiao, Jipan, Xie, Martin, Blogg, Budiwan, Sumarsono, Soyoung, Kim
Publikováno v: Menopause. 29:553-563
To understand prevalence, severity, impact, and treatment of vasomotor symptoms associated with menopause, using cross-sectional survey data.This online, two-part survey was conducted in East Asia among women 40-65 years recruited from established on
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::605a4fe1e774c4401fcb87f29696501b
https://doi.org/10.1097/gme.0000000000001949
Zobrazit plný text záznamu
7
Cardiovascular safety of mirabegron add‐on therapy to tamsulosin for the treatment of overactive bladder in men with lower urinary tract symptoms: A post hoc analysis from the MATCH study
Autor: Kota Ishida, Budiwan Sumarsono, Osamu Yamamoto, Jar Jar Jong, Osamu Yamaguchi, Hidehiro Kakizaki, Satoshi Uno, Kyu-Sung Lee, Takao Katoh, Daisuke Katou
Publikováno v: Lower Urinary Tract Symptoms
Objectives To investigate the cardiovascular safety of mirabegron add‐on treatment to tamsulosin in male patients with residual overactive bladder symptoms. Methods This was a post hoc analysis of MATCH, the first double‐blind, placebo‐controll
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::756155fc1f92aa06a9faade814edffe1
https://doi.org/10.1111/luts.12339
Zobrazit plný text záznamu
8
Mirabegron Add-on Therapy to Tamsulosin for the Treatment of Overactive Bladder in Men with Lower Urinary Tract Symptoms: A Randomized, Placebo-controlled Study (MATCH)
Autor: Osamu Yamaguchi, Budiwan Sumarsono, Daisuke Katou, Osamu Yamamoto, Kyu-Sung Lee, Jar Jar Jong, Hidehiro Kakizaki, Satoshi Uno
Publikováno v: European Urology Focus. 6:729-737
Background Men with lower urinary tract symptoms (LUTS) treated with α-blockers (eg, tamsulosin) may experience overactive bladder (OAB) symptoms and receive add-on antimuscarinics. Mirabegron (a β3-adrenoreceptor agonist) is an alternative add-on
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4aa6bf68b3075537333c5a67df56ceff
https://doi.org/10.1016/j.euf.2019.10.019
Zobrazit plný text záznamu
9
Mirabegron add-on therapy to tamsulosin in men with overactive bladder: Post-hoc analyses of efficacy from the MATCH study
Autor: Kyu-Sung Lee, Hidehiro Kakizaki, Satoshi Uno, Osamu Yamaguchi, Budiwan Sumarsono, Daisuke Katou, Osamu Yamamoto
Publikováno v: European Urology Open Science, Vol 19, Iss, Pp e633-(2020)
Advances in Therapy
Introduction MATCH was a randomized, double-blind, placebo-controlled study enrolling Japanese and Korean men aged ≥ 40 years who still had overactive bladder (OAB) symptoms while receiving tamsulosin. After a 4-week single-blind screening period i
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c8d4965277f1ad5293257ae01ad2b9d
http://www.sciencedirect.com/science/article/pii/S2666168320329943
Zobrazit plný text záznamu
10
The prevalence of lower urinary tract symptoms in population aged 40 years or over, in South Korea
Autor: Sun-Hwa Kim, Sung-Tae Kim, Hyun-Jung Kim, Kyu-Sung Lee, Tag Keun Yoo, Hyun-Cheol Lee, Budiwan Sumarsono
Publikováno v: Investigative and Clinical Urology
Investigative and Clinical Urology, Vol 59, Iss 3, Pp 166-176 (2018)
Purpose Lower urinary tract symptoms (LUTS) can be distressing and socially isolating, and the economic impact can be substantial. Further data to characterize the epidemiology and effects of LUTS in South Korea would be beneficial. Materials and met
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60e36487c9620d78a33fccd3a5363e63
http://europepmc.org/articles/PMC5934278
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje